James “Jim” Sigg FDA's Deputy Commissioner for Operations and Chief Operating Officer | Official Website
James “Jim” Sigg FDA's Deputy Commissioner for Operations and Chief Operating Officer | Official Website
This is an increase over the number of companies cited in the previous year.
The citations in the county include:
- Procedures for training and identifying training needs have not been adequately established.
- The design history file does not demonstrate that the design was developed following the requirements of 21 CFR 820.
- Procedures to ensure that all purchased or otherwise received product and services conform to specified requirements have not been adequately established.
The company cited should take a voluntary action to correct its managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
Signal Medical Corporation | Devices | 04/10/2023 | Training - Lack of or inadequate procedures |
Signal Medical Corporation | Devices | 04/10/2023 | Design history file |
Signal Medical Corporation | Devices | 04/10/2023 | Purchasing controls, Lack of or inadequate procedures |
Signal Medical Corporation | Devices | 04/10/2023 | Statistical techniques - Lack of or inadequate procedures |